Cargando…
Identification of PDHX as a metabolic target for esophageal squamous cell carcinoma
The metabolism in tumors is reprogrammed to meet its energetic and substrate demands. However, this metabolic reprogramming creates metabolic vulnerabilities, providing new opportunities for cancer therapy. Metabolic vulnerability as a therapeutic target in esophageal squamous cell carcinoma (ESCC)...
Autores principales: | Inoue, Jun, Kishikawa, Masahiro, Tsuda, Hitoshi, Nakajima, Yasuaki, Asakage, Takahiro, Inazawa, Johji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253269/ https://www.ncbi.nlm.nih.gov/pubmed/33964039 http://dx.doi.org/10.1111/cas.14938 |
Ejemplares similares
-
Augmentation of lenvatinib efficacy by topical treatment of miR-634 ointment in anaplastic thyroid cancer
por: Kishikawa, Masahiro, et al.
Publicado: (2021) -
Subcloning and characterization of highly metastatic cells derived from human esophageal squamous cell carcinoma KYSE150 cells by in vivo selection
por: Okuda, Masafumi, et al.
Publicado: (2017) -
Integrative genome‐wide analyses reveal the transcriptional aberrations in Japanese esophageal squamous cell carcinoma
por: Takemoto, Akira, et al.
Publicado: (2021) -
MicroRNA-26a regulates glucose metabolism by direct targeting PDHX in colorectal cancer cells
por: Chen, Bing, et al.
Publicado: (2014) -
Potential for reversing miR-634-mediated cytoprotective processes to improve efficacy of chemotherapy against oral squamous cell carcinoma
por: Tran, Phuong Xuan, et al.
Publicado: (2022)